These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 17895301
1. Clinical and serological follow-up of 71 patients with anti-mitochondrial type 5 antibodies. Andrejevic S, Bonaci-Nikolic B, Sefik-Bukilica M, Petrovic R. Lupus; 2007; 16(10):788-93. PubMed ID: 17895301 [Abstract] [Full Text] [Related]
2. [Anti-mitochondrial antibodies type 5 are markers of antiphospholipid syndrome]. Laperche S, Abuaf N, Deschamps A, Homberg JC. Ann Biol Clin (Paris); 1994; 52(5):375-9. PubMed ID: 7856938 [Abstract] [Full Text] [Related]
5. Anti-mitochondrial M5 type antibody represents one of the serological markers for anti-phospholipid syndrome distinct from anti-cardiolipin and anti-beta2-glycoprotein I antibodies. La Rosa L, Covini G, Galperin C, Catelli L, Del Papa N, Reina G, Morabito A, Balestrieri G, Tincani A, Gershwin ME, Meroni PL. Clin Exp Immunol; 1998 Apr; 112(1):144-51. PubMed ID: 9566803 [Abstract] [Full Text] [Related]
6. Antimitochondrial antibodies in patients with chronic hepatitis C virus infection: description of 18 cases and review of the literature. Ramos-Casals M, Pares A, Jara LJ, Solans R, Viñas O, Vázquez P, Sánchez-Tapias JM, Rodés J, Font J, HISPAMEC Study Group*. J Viral Hepat; 2005 Nov; 12(6):648-54. PubMed ID: 16255767 [Abstract] [Full Text] [Related]
7. Serum immunological profile in patients with chronic autoimmune cholestasis. Romero-Gómez M, Wichmann I, Crespo J, Parés A, Rodrigo L, Alvarez A, Diago M, Pons-Romero F, Sanchez-Munoz D, Aguilar-Reina J, Andrade RJ, Salmeron J, Sánchez-Pobre P, Rebollo JM, Martin-Vivaldi R, Castellano-Megias V, Nuñez-Roldan A, Bruguera M, Spanish Group for the Study of Autoimmune Cholangitis. Am J Gastroenterol; 2004 Nov; 99(11):2150-7. PubMed ID: 15554996 [Abstract] [Full Text] [Related]
8. Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome. Blank M, Krause I, Magrini L, Spina G, Kalil J, Jacobsen S, Thiesen HJ, Cunningham MW, Guilherme L, Shoenfeld Y. Rheumatology (Oxford); 2006 Jul; 45(7):833-41. PubMed ID: 16705050 [Abstract] [Full Text] [Related]
10. Anti-beta(2)-glycoprotein I autoantibody expression as a potential biomarker for strokes in patients with anti-phospholipid syndrome. Ali HY, Abdullah ZA. J Immunotoxicol; 2008 Apr 27; 5(2):173-7. PubMed ID: 18569388 [Abstract] [Full Text] [Related]
11. Val/Leu247 polymorphism of beta2-glycoprotein I in Brazilian patients with antiphospholipid syndrome--a genetic risk factor? Pernambuco-Climaco JM, Brochado MJ, Freitas MV, Roselino AM, Louzada-Junior P. Ann N Y Acad Sci; 2009 Sep 27; 1173():509-14. PubMed ID: 19758193 [Abstract] [Full Text] [Related]
12. Prevalence and clinical significance of anticardiolipin, anti-beta2-glycoprotein-1, and anti-heat shock protein-70 autoantibodies in sudden sensorineural hearing loss. Gross M, Eliashar R, Ben-Yaakov A, Ulmansky R, Elidan J. Audiol Neurootol; 2008 Sep 27; 13(4):231-8. PubMed ID: 18259075 [Abstract] [Full Text] [Related]
13. [Clinical significance of anti-phosphatidylserine-prothrombin complex antibodies in antiphospholipid syndrome]. Kaburaki J, Kuwana M, Kameda H, Takeuchi T, Okada J, Katayama M, Yoshida S, Ikeda Y. Rinsho Ketsueki; 2005 Jan 27; 46(1):19-21. PubMed ID: 16708913 [Abstract] [Full Text] [Related]
14. [A prospective study on the prevalence and clinical significance of autoantibodies in patients with suspected nonalcoholic fatty liver disease]. Cho DH, Choi MS, Kim DH, Kim DY, Shim SG, Lee JH, Koh KC, Paik SW, Yoo BC, Rhee JC. Korean J Hepatol; 2005 Sep 27; 11(3):261-7. PubMed ID: 16177552 [Abstract] [Full Text] [Related]
15. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus. Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E. Autoimmunity; 2009 Sep 27; 42(6):497-506. PubMed ID: 19626489 [Abstract] [Full Text] [Related]
16. The frequency of anti-beta2-glycoprotein I antibodies is low and these antibodies are associated with pulmonary hypertension in mixed connective tissue disease. Hasegawa EM, Caleiro MT, Fuller R, Carvalho JF. Lupus; 2009 Jun 27; 18(7):618-21. PubMed ID: 19433462 [Abstract] [Full Text] [Related]
17. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis. Liu B, Shi XH, Zhang FC, Zhang W, Gao LX. Liver Int; 2008 Feb 27; 28(2):233-9. PubMed ID: 18251980 [Abstract] [Full Text] [Related]
18. Autoantibody explosion in antiphospholipid syndrome. Shoenfeld Y, Twig G, Katz U, Sherer Y. J Autoimmun; 2008 Feb 27; 30(1-2):74-83. PubMed ID: 18171610 [Abstract] [Full Text] [Related]
19. Increased serum aminotransferases associated with anti-mitochondrial antibodies in systemic lupus erythematosus patients with autoimmune liver disease. Li CH, Xu PS, Wang CY, Zou GL. Clin Chim Acta; 2006 Mar 27; 365(1-2):135-42. PubMed ID: 16182269 [Abstract] [Full Text] [Related]
20. Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism. Pengo V, Bison E, Ruffatti A, Iliceto S. Thromb Res; 2008 Mar 27; 122(4):556-9. PubMed ID: 18328538 [Abstract] [Full Text] [Related] Page: [Next] [New Search]